Neuropharmacology and Drug Development
This track focuses on the development and action of drugs that influence nervous system function. Neuropharmacology studies how pharmaceutical agents affect neurotransmitter systems such as dopamine, serotonin, and GABA, which are critical for mood regulation, cognition, and pain processing. It covers both basic research and applied studies in drug discovery, efficacy testing, and side effect profiling. With neuropsychiatric disorders on the rise, this area is central to advancing safe and effective treatments. Attendees will explore preclinical models, receptor targeting strategies, and the latest innovations in CNS drug development including nanotechnology and precision medicine.
